gene_symbol
UNKNOWN
binding_type
antigen recognition
cytotoxicity
YES
cytotoxicity_type
DIRECT
cytotoxicity_mechanism
Engineered cytotoxic lymphocytes recognize the tumor-associated antigen and kill target cells via immune synapse formation and perforin/granzyme-mediated cytolysis (with cytokine-driven cytotoxicity).
enzyme_product
Off
epitope
Off
variant
Off
isoform
Off
hla_specific
Off
gated
Off
other_modifier
Target antigen not specified in the registry; enrollment requires positive tumor expression in esophageal, gastric, pancreatic, or colorectal cancers.
trial_id_tar_ref
drug_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT06104215
disease_id_num_tar_ref
2627
drug_id_num_tar_ref
7007